Evaluation of Influenza A/Hong Kong/123/77 (H1N1) ts -1A2 and Cold-Adapted Recombinant Viruses in Seronegative Adult Volunteers

Author:

Murphy Brian R.1,Rennels Margret B.2,Douglas R. Gordon3,Betts Robert F.3,Couch Robert B.4,Cate Thomas R.4,Chanock Robert M.1,Kendal Alan P.5,Maassab Hunien F.6,Suwanagool Surapol2,Sotman Steven B.2,Cisneros Luis A.2,Anthony William C.2,Nalin David R.2,Levine Myron M.2

Affiliation:

1. Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20205

2. Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201

3. University of Rochester School of Medicine, Rochester, New York 14627

4. Baylor College of Medicine, Houston, Texas 77000

5. Center for Disease Control, Atlanta, Georgia 30333

6. Department of Epidemiology, University of Michigan, School of Public Health, Ann Arbor, Michigan 43104

Abstract

Two attenuated influenza A donor viruses, the A/Udorn/72 ts -1A2 and the A/Ann Arbor/6/60 cold-adapted ( ca ) viruses, are being evaluated for their ability to reproducibly attenuate each new variant of influenza A virus to a specific and desired level by the transfer of one or more attenuating genes. Each of these donor viruses has been able to attenuate influenza A viruses belonging to the H3N2 subtype by the transfer of one or more attenuating genes. To determine whether these two donor viruses could attenuate a wild-type virus that belonged to a different influenza A subtype, ts -1A2 and ca recombinants of a wild-type virus representative of the A/USSR/77 (H1N1) Russian influenza strain were prepared and evaluated in adult doubly seronegative volunteers at several doses. The recombinants derived from both donor viruses were attenuated for the doubly seronegative adults. Less than 5% of infected vaccinees developed a febrile or systemic reaction, whereas five of six recipients of wild-type virus developed such a response. The 50% human infectious dose (HID 50 ) for each recombinant was approximately 10 5.0 50% tissue culture infective doses. The virus shed by the ts -1A2 and ca vaccinees retained the ts or ca phenotype, or both. This occurred despite replication of the recombinant viruses for up to 9 days. No evidence for transmission of the ca or ts -1A2 recombinant virus to controls was observed. A serum hemagglutination inhibition response was detected in less than 50% of the infected vaccinees. However, with the more sensitive enzyme-linked immunosorbent assay, a serological response was detected in 100% of the ca vaccinees given 300 HID 50 and approximately 70% of ca or ts vaccinees who received 10 to 32 HID 50 of virus. These results indicate that the recombinants derived from both donor viruses were satisfactorily attenuated and were stable genetically after replication in doubly seronegative adults although they induced a lower serum hemagglutination inhibition response than that found previously for H3N2 ts and ca recombinants.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Immunology,Microbiology,Parasitology

Reference25 articles.

1. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 250 between recent H3N2 and HINl epidemic strains and coldadapted A/Ann Arbor/60;Cox N. J.;Virology,1979

2. Pilot studies on recombinant coldadapted live type A and B influenza virus vaccines;Davenport F. M.;J. Infect. Dis.,1977

3. The Russian flu-its history and implications for this year's influenza season;Gregg M. B.;J. Am. Med. Assoc.,1978

4. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a coldadapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers;Hrabar A.;Dev. Biol. Stand.,1977

5. Isaacs A. A. W. Gledhill and C. H. Andrews. 1952. Influenza A viruses: laboratory studies with special reference to European outbreaks of 1950-55. Bull. W. H. 0. 6:287-315.

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3